Speaker
Colby Souders, Senior Director of R&D
In this webinar, our team of antibody experts in Abveris will discuss the following topics:
• Rapid, efficient discovery of monoclonal antibodies against traditionally difficult targets, including cell surface receptors with complex specificity and functionality requirements
• The advantages of the Abveris single-cell workflow (enabled by the Berkeley Lights Beacon®) as compared to other B cell screening platforms
• The advantages of incorporating genetically modified hyperimmune mouse models (DiversimAb™) into in vivo antibody discovery workflows that can greatly increase the likelihood of identifying antibodies binding non-immunodominant, functionally relevant epitopes
• A case study highlighting rapid antibody Beacon-based discovery against a cell surface receptor for which functional activity was paramount to success
Overview of screening technologies for anti-Id antibodies discovery.
Dos and don'ts when planning and designing anti-Id discovery campaigns
Case studies of hybridoma-based and Beacon-based anti-Id campaigns targeting therapeutic biologics
Click the link below to schedule a meeting with one of our scientists!
